Sangamo Announces AAV Capsid Data

Sangamo Therapeutics Announces Participation at Upcoming Investor Conferences

BRISBANE, Calif. --(BUSINESS WIRE)--Feb. 28, 2022-- Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that management will be participating in the following investor conferences: Cowen 42 nd Annual Health Care Conference Date: Monday, March 7 th at 12:50 p.m.